|
|
Volumn 12, Issue 2, 2001, Pages 173-174
|
|
Bioprocessing of therapeutic proteins
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
MONOCLONAL ANTIBODY;
RECOMBINANT PROTEIN;
BIOPROCESS;
CELL CULTURE;
CONTROLLED STUDY;
DRUG DELIVERY SYSTEM;
DRUG INDUSTRY;
EDITORIAL;
EUROPE;
HEALTH CARE;
HUMAN;
LICENSING;
MAMMAL CELL;
PHARMACEUTICAL ENGINEERING;
PRIORITY JOURNAL;
PROTEIN PURIFICATION;
UNITED STATES;
ANIMAL;
BIOSYNTHESIS;
ESCHERICHIA COLI;
GENETICS;
METHODOLOGY;
PROTEIN ENGINEERING;
MAMMALIA;
ANIMALS;
CELLS, CULTURED;
ESCHERICHIA COLI;
PROTEIN ENGINEERING;
RECOMBINANT PROTEINS;
|
|
EID: 0035313661
PISSN: 09581669
EISSN: None
Source Type: Journal
DOI: 10.1016/S0958-1669(00)00195-6 Document Type: Article |
|
Times cited : (32)
|
|
References (7)
|
